Voluntary Product Recall
2 lots of Allerject (0.15 mg / 0.15 mL) distributed as of June 1 2015


Please find below the information about Sanofi’s voluntary recall of 2 lots of Allerject 0.15 mg / 0.15 mL epinephrine auto injectors. Check your device to see if it is included in the recall and kindly forward this information to others who may be affected.
Thank you -
Anaphylaxis Canada

On Friday, June 12, 2015 Sanofi Canada took the precautionary measure of issuing a Voluntary Recall of Allerject 0.15 mg / 0.15 mL epinephrine auto injectors, lots 2857505 and 2857508, distributed as of June 1st, 2015, due to a manufacturing defect that could potentially affect the delivery of the drug. The defect was discovered as part of a routine manufacturer quality review process. Allerject 0.15 mg / 0.15 mL is the pediatric version of the epinephrine auto injector. No other lots or strengths of Allerject, or any other Sanofi Canada products are included in this recall. The two lots subject to the recall were distributed solely in Canada. There have been no reports of patients adversely affected by the 2 lots distributed to date.

Sanofi Canada is committed to the health and well-being of patients and consumers using its products. This voluntary recall is conducted in collaboration with the Health Products and Food Branch Inspectorate of Health Canada which has issued a communications relating to the recall.

To ensure the safety of children at risk of anaphylaxis we would ask that you add Health Canada’s notice to your website and communicate it through your social media channels. Sanofi Canada is contacting healthcare practitioners, retail pharmacists, hospitals and stakeholders to inform them of the recall. We will also be issuing a press release.

We are informing the public that should they be in possession of an affected product, they should immediately return the product to their local pharmacy for replacement.

Patients with questions or concerns should contact the Allerject Call Center at 1-855-405-4321. Customers with questions relating to product return logistics should contact Sanofi Customer Service at 1-800-265-7927.

Thank you for your support in helping us communicate this matter. The safety of our patients is our highest priority.

PRODUCT IDENTIFICATION
Name
French: Allerject 0.15 mg / 0.15 mL epinephrine injection
English: Allerject 0.15 mg / 0.15 mL epinephrine injection
UPC 065914 11216 4 065914 11217 1
DIN/NPN/Device 02382059
Lot(s)
2857505 (French) Expiry Sep 2016
2857508 (English) Expiry Sep 2016


Note that other lots are NOT affected by this recall

Hot Topics

Mississauga Anaphylaxis Education Group Update

June 18, 2015

Anaphylaxis Canada would like to sincerely express its thanks to Penny Anderson for serving five years as a support group leader of the Mississauga Anaphylaxis Education Group. Since the group was founded 10 years ago, countless people who have food allergies or at risk for anaphylaxis attended events for adults and kids, educational seminars and support meetings throughout the Mississauga region.

If you live in Mississauga or the surrounding area and are interested in starting a support group, please contact Anaphylaxis Canada office at 1-866-785-5660 or 416-785-5666.

Who is your Allergy Hero?



Announcing The Summer of TAG (Treating Allergies with Genuine Care) 2015


Anaphylaxis Canada is proud to be named once again the charity of choice by Canadian race car driver Alex Tagliani. Working together to help promote food allergy awareness and safety, The Summer of TAG, is a joint initiative undertaken by Alex and Anaphylaxis Canada, with the support of Pfizer Canada (Canadian distributor of EpiPen®).

The Summer of TAG will kick off with Alex’s visits to Vancouver and Edmonton on May 7th and 8th. Alex will be joined by local allergists who will help educate families on how to safely manage food allergies and the importance of always being prepared for an emergency. For more information on his upcoming visits click here


Voici l’Été de TAG (Traiter les Allergies avec Grand soin)


Anaphylaxie Canada est heureuse d’avoir été choisie de nouveau à titre d’organisme de bienfaisance par le coureur automobile Alex Tagliani. Faisant équipe pour sensibiliser les gens aux allergies alimentaires et promouvoir la sécurité, l’Été de TAG est une initiative conjointe pilotée par Alex et Anaphylaxie Canada bénéficiant du soutien de Pfizer Canada (distributeur canadien d’EpiPenMD).

L’Été de TAG prendra son envol avec les visites d’Alex à Vancouver et à Edmonton les 7 et 8 mai. Alex sera accompagné d’allergologues de ces régions qui l’aideront à éduquer les familles relativement à la gestion sécuritaire des allergies alimentaires et à l’importance de toujours être prêt à faire face à une situation d’urgence. Pour plus d’information sur ses prochaines visites ici
Events